These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 9421697)

  • 1. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.
    Spencer CM; Goa KL; Gillis JC
    Drugs; 1997 Dec; 54(6):925-75. PubMed ID: 9421697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
    Plosker GL; Foster RH
    Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.
    Peters DH; Fitton A; Plosker GL; Faulds D
    Drugs; 1993 Oct; 46(4):746-94. PubMed ID: 7506654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
    Dunn CJ; Wagstaff AJ; Perry CM; Plosker GL; Goa KL
    Drugs; 2001; 61(13):1957-2016. PubMed ID: 11708766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk-benefit assessment of tacrolimus in transplantation.
    Winkler M; Christians U
    Drug Saf; 1995 May; 12(5):348-57. PubMed ID: 7545405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
    Saudek F; Malaise J; Boucek P; Adamec M;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant diabetes mellitus. The role of immunosuppression.
    Jindal RM; Sidner RA; Milgrom ML
    Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring tacrolimus-based immunotherapy in renal transplantation.
    Yang HC
    Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i16-20. PubMed ID: 12738759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of liver and gastrointestinal transplantation at the University of Miami.
    Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG
    Clin Transpl; 1996; ():187-201. PubMed ID: 9286568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacokinetics and therapeutic monitoring of tacrolimus].
    Garraffo R
    Therapie; 1997; 52(4):345-52. PubMed ID: 9437890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.
    U.S. Multicenter FK506 Liver Study Group
    N Engl J Med; 1994 Oct; 331(17):1110-5. PubMed ID: 7523946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus: a new immunosuppressive agent.
    Kelly PA; Burckart GJ; Venkataramanan R
    Am J Health Syst Pharm; 1995 Jul; 52(14):1521-35. PubMed ID: 7552894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.